Avulux Patient Feedback: Get Your Patients Back to What They Love
Migraine is a genetic neurological disease that affects nearly 48 million people in the United States — that’s almost 1 in 5 patients in your practice.
Business insights and articles written by our team of world-class professionals
Migraine is a genetic neurological disease that affects nearly 48 million people in the United States — that’s almost 1 in 5 patients in your practice.
Avulux is proud to announce formal partnerships with Opti-Port, the eye care industry’s only alliance of growth-oriented, multi-office eye care practices, and with PERC, a collective purchasing organization committed to helping optometric practices boost profitability.
Research shows that approximately 80 to 90 percent of patients with migraine report light sensitivity during attacks, and 49 percent report that light sensitivity is their most bothersome symptom during a headache.
Eyenavision and Avulux today launched Chemistrie Avulux, an innovative new on-demand eyeglass clip option for people living with migraine and light sensitivity.
While FL-41 might have been commonly used in the past, Avulux represents an evolution in precision light filtering technology that offers superior and consistent light filtration for patients living with migraine and light sensitivity.
Mr. Southwell will be responsible for leading Avulux’s business-to-business commercial strategy including sales, account management, strategic partnerships, distribution, professional development, and marketing integration.
One of the key objectives of IDOC is to offer a full range of products and services designed to enable competitive advantage in optometry practice management, thereby helping eye care providers to attain long-term business growth.
Avulux, the innovator behind the world’s only clinically proven lens for people living with migraine and light sensitivity, is pleased to welcome the John A. Moran Eye Center to its growing network of eye care providers.
Did you know that June is Migraine Awareness Month? We’d bet that as many as one in five of your patients know – because they experience migraine themselves.
Log into the Avulux Resource Center to access Avulux marketing assets, training and education materials, and to learn about upcoming events and promotions.